NDC 33342-294 – Fenofibric acid
Choline Fenofibrate 45 mg/1 · Capsule, Delayed Release · Oral
Product NDC33342-294
Product details
- Brand name
- Fenofibric acid
- Generic name
- Fenofibric acid
- Labeler
- Macleods Pharmaceuticals Limited
- Dosage form
- Capsule, Delayed Release
- Route
- Oral
- Marketing category
- ANDA · ANDA207796
- Marketed since
- February 26, 2024
- Listing expires
- December 31, 2026
- Pharmacologic class
- Peroxisome Proliferator Receptor alpha Agonist
Active ingredients
- Choline Fenofibrate 45 mg/1
Uses, dosage, side effects and warnings for Fenofibric acid →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 33342-294-10 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (33342-294-10) | Feb 26, 2024 |
| 33342-294-12 | 10 BLISTER PACK in 1 CARTON (33342-294-12) / 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK | Feb 26, 2024 |
Other Fenofibric acid products
- 62332-244 Fenofibric Acid 45 mg/1 · Capsule, Delayed Release · Alembic Pharmaceuticals Inc.
- 62332-245 Fenofibric Acid 135 mg/1 · Capsule, Delayed Release · Alembic Pharmaceuticals Inc.
- 46708-244 Fenofibric Acid 45 mg/1 · Capsule, Delayed Release · Alembic Pharmaceuticals Limited
- 46708-245 Fenofibric Acid 135 mg/1 · Capsule, Delayed Release · Alembic Pharmaceuticals Limited
- 0115-1324 Fenofibric Acid 45 mg/1 · Capsule, Delayed Release · Amneal Pharmaceuticals of New York LLC
- 0115-1325 Fenofibric Acid 135 mg/1 · Capsule, Delayed Release · Amneal Pharmaceuticals of New York LLC
- 59651-216 Fenofibric Acid 45 mg/1 · Capsule, Delayed Release · Aurobindo Pharma Limited
- 59651-217 Fenofibric Acid 135 mg/1 · Capsule, Delayed Release · Aurobindo Pharma Limited
- 69315-281 Fenofibric Acid 45 mg/1 · Capsule, Delayed Release · Leading Pharma, LLC
- 69315-282 Fenofibric Acid 135 mg/1 · Capsule, Delayed Release · Leading Pharma, LLC
- 68180-128 Choline Fenofibrate 45 mg/1 · Capsule, Delayed Release · Lupin Pharmaceuticals, Inc.
- 68180-129 Choline Fenofibrate 135 mg/1 · Capsule, Delayed Release · Lupin Pharmaceuticals, Inc.